Food and Drug Administration Commissioner Marty Makary is resigning after thirteen months in office following conflicts with the White House over vaping, drug, and abortion pill policies.His tenure was marked by massive turnover among senior officials and inconsistent regulatory shifts that frustrated industry partners and political allies.Kyle Diamantas is slated to take over as acting commissioner while the administration navigates ongoing scrutiny of the agency's vaccine and drug review practices.The departure follows intense pressure from vaping industry lobbyists and anti-abortion advocates seeking to reverse existing agency health directives.